News

New York - With postexcision recurrence rates of 30 percent , Mohs surgery might be the better alternative in the treatment of sebaceous gland carcinoma, according to James M. Spencer, M.D.)

New Orleans - It is time for dermatologists to incorporate a new generation of active wound treatment products, Anna Falabella M.D., said at the annual meeting of the American Academy of Dermatology.

New Orleans - Systemic contact dermatitis may present with a variety of eczematous and noneczematous cutaneous reaction patterns and may be an overlooked diagnosis unless clinicians maintain an index of suspicion that systemic exposure to a contact allergen is driving the skin eruption, Donald V. Belsito, M.D., said at the annual meeting of the American Academy of Dermatology.

New Orleans - Dermatologists need to be aware that hepatitis C virus (HCV) infection may present with cutaneous manifestations because early diagnosis and treatment are critical for reducing morbidity and mortality from progression of the underlying infectious disease, Julia R. Nunley, M.D., said at the annual meeting of the American Academy of Dermatology.

New Orleans - Even with fairly recent advances in the testing and treatment of mycosis fungoides, difficulties still remain with the diagnosis of the rare, slowly progressing cutaneous lymphoma, David P. Fivenson, M.D., said at the annual meeting of the American Academy of Dermatology.

New Orleans - Simple measures can help alleviate any burning and stinging experienced by patients undergoing 5-ALA photodynamic therapy for treatment of actinic keratoses, Joseph Fowler, Jr., M.D., said at the annual meeting of the American Academy of Dermatology.

New Orleans - Rhinophyma resection needs to be performed in a way that allows for postoperative histopathologic study, according to Luis A. Lopardo, MD, speaking here at the 60th annual meeting of the American Academy of Dermatology.

New Orleans - The experiences of an expanding series of patients indicate infliximab (Remicade) is a valuable therapy for the management of pyoderma gangrenosum (PG), Marketa Limova, M.D., said at the annual meeting of the American Academy of Dermatology.

Maui, Hawaii - Alefacept (Amevive) for treating patients with chronic plaque psoriasis provides clinical benefits that may be long-term and are associated with significant improvement in quality of life, Mark Lebwohl, M.D., said at the 26th annual Hawaii Dermatology Seminar.

Dallas - Use of centrifuged fat yields better long-term aesthetic results for lipoaugmentation of the hands than does a technique based on noncentrifuged fat,

New Orleans - Photosensitivity is an important clue to connective tissue disease, and new studies are focusing on animal models to determine the mechanisms of the link,

New Orleans - Determining the relative risk of a cutaneous drug reaction pattern is vital to determining whether the drug(s) in question can be continued currently or rechallenged in the future,

New Orleans - Oral bexarotene (Targretin) appears to be a good palliative treatment for patients with recalcitrant late-stage S?zary syndrome, but

Rouen, France - Topical corticosteroid treatment is effective for both moderate and severe bullous pemphigoid.

New Orleans - Dermatologists should treat bullous hemorrhagic cellulitis as a medical emergency, Francisco Kerdel, M.D., said, because "if you don't, the patient can lose an arm or a leg - or die."

As Internet authority Steve Litt has noted: Never get personal. Never say "you're an idiot" or "you're a hypocrite," and try to avoid saying "you're wrong." No matter how true the statement, it's almost guaranteed to generate a heavy-handed response that will just draw you into a potentially dangerous and unprofitable conflict.

Q. How are the new Section 529 education plans impacted by annual gifting limits, and are they protected in the event that I am sued?

If money grew on trees, if Sept. 11 and the recession hadn't happened, and if the federal budget wasn't in deficit once again, dermatologists and other physicians might see last year's 5.4 percent Medicare payment cut rescinded by a generally sympathetic Congress

Maui, Hawaii - Already FDA-approved for scalp psoriasis, clobetasol propionate foam is effective against mild to moderate psoriasis in other parts of the body as well.

Q. What is the benefit of the new facial cleansing cloths?A. The newest way to clean the face is use of a disposable single-use cleansing cloth impregnated with a cleanser. These cloths are made in two varieties for normal to oily skin and normal to dry skin, with designs particular to each ailment.

Q. What factors determine the SPF performance of a given sunscreen?A. The SPF is the sun protection factor afforded by a given sunscreen. It is determined by dividing the lower back of untanned individuals is into small test sites which are exposed to UVB light until a minimum amount of erythema develops, known as the MED. Lightproof barriers are placed around the test sites to prevent light contamination from one test site to another. Once the MED for the test subject has been determined, the subject is invited to return to the test site the next day for application of sunscreen. The sunscreen is placed on the test sites and allowed to dry. The skin is then exposed to UVB light at the expected SPF of the sunscreen product. The expected SPF is roughly determined by spectrophotometric absorption. The amount of UVB light required to obtain the same degree of erythema as the preceding day is determined and the SPF calculated.

New Orleans - Results from a single-center pilot study indicatethat I.V. alefacept (Amevive), the human LFA3-IgG1 fusion protein, may safelyand effectively improve the skin and joint manifestations of psoriatic arthritis,researchers from the Academic Medical Center, University of Amsterdam, TheNetherlands, reported at the annual meeting of the American Academy of Dermatology.

Jane, a very mature 17-year-old adolescent, presents to Dr. Jones forremoval of a facial nevus. Dr. Jones discusses the risk/benefit ratio ofsuch an excision. In the course of the discussion, he determines that sheis working a full-time job and lives with her boyfriend at home with herparents. She signs a standard consent form. Dr. Jones does not realize thatshe is 17; he did not ask. Ultimately she is not happy with the scar andwishes to sue her dermatologist. The basis of her suit is that at age 17she was not able to provide informed consent. Dr. Jones is aware that, asa general rule, a patient must be 18 years of age to provide informed consent.However, he contends that Jane was highly intelligent, articulate and hada better understanding of the procedure than some 19 year olds might have.Can Jane, as an adolescent, give informed consent?

New Orleans - Polymixin B sulfate/bacitracin zinc/neomycin applied either as a topical ointment or in an over-the-counter bandage effectively eliminates Staphylococcus aureus colonization in wounds,

New Orleans - Although the natural history and imaging characteristics of hemangiomas are well known, some new or relatively new observations have led to further sub-categorization, Patricia E. Burrows, M.D., said at the 60th annual meeting of the American Academy of Dermatology.

New Orleans - The experience of a teenage girl treated successfully with infliximab (Remicade) for severe, recalcitrant psoriasis of her hands and feet indicates the value of the TNF-alpha chimeric monoclonal antibody as a therapeutic option for psoriasis.

New Orleans - Results from an exploratory study indicate a potential role for topical tacrolimus in the management of vitiligo, Emil A. Tanghetti, M.D., said at the annual meeting of the American Academy of Dermatology.

New Orleans - A combination therapy used in Canada to treat wrinkles and skin folds figures to draw the interest and eventual use of U.S.-based cosmetic surgeons.

New Orleans - Second intention healing with a calcium alginate dressing can be a useful alternative for closing skin-cancer excision facial defects in select patients who might otherwise be managed with primary closure, local flaps, or skin grafts, Roger H. Weenig, M.D., M.P.H., said at the annual meeting of the American Academy of Dermatology.

Rockville, Md. - A three-drug combination for the treatment of melasma is available as a single formula after being used separately since the 1970s.